Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of
delayed culture conversion with continued transmission in the community, as well as …

Background The development of drug-resistant (DR) tuberculosis (TB) has become an
increasing concern over the past few decades as the result of numerous factors, including …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

Background Poor adherence to tuberculosis (TB) treatment can lead to prolonged infectivity
and poor treatment outcomes. Directly observed treatment (DOT) seeks to improve …

Background Directly observed therapy (DOT), as recommended by the World Health
Organization, is used in many countries to deliver tuberculosis (TB) treatment. The …

Background Non-adherence to tuberculosis (TB) treatment is the leading contributor to the
selection of drug-resistant strains of Mycobacterium tuberculosis and subsequent treatment …

Objective: To analyze actions promoting adherence to tuberculosis treatment that are being
carried out by nurses in different countries. Method: Scoping review with selection of articles …

Globally and in South African specifically, men account for 56% and 62% of all tuberculosis
(TB) cases, respectively. Men are at increased risk of not accessing TB testing or treatment …